Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

NCT07700225 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT07700225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07700225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
Lead sponsor
Virginia Commonwealth University
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2026
Completion date
December 31, 2032
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dm1, myotonic dystrophy, myotonic dystrophy 1, myotonic dystrophy type 1, myotonic dystrophy type-1, myotonic dystrophy, type 1 (dm1), myotonic muscular dystrophy